https://www.marketscreener.com/quote/stock/QUALIGEN-THERAPEUTICS-INC-42489916/news/Qualigen-Therapeutics-Partners-with-TD2-for-Phase-1-Clinical-Development-of-QN-302-for-the-Treatment-44639912/?utm_source=telegram&utm_medium=social&utm_campaign=share